Table 4 Differences in rates of decline in eGFR (mL·min-1·1.73 m-2·yr-1, mean ± standard error) within genders and between groups when proteinuria was used to define CKD
Health group (n = 4660) | Risk group (n = 8566) | CKD group (n = 341) | ||||
|---|---|---|---|---|---|---|
Male (n = 1353) | Female (n = 3307) | Male (n = 3836) | Female (n = 4730) | Male (n = 130) | Female (n = 211) | |
Unadjusted rates of decline in eGFR | 0.52 ± 0.04* | 0.75 ± 0.03 | 0.52 ± 0.02* | 0.67 ± 0.02 | 0.97 ± 0.08 | 0.91 ± 0.07 |
Covariate-adjusted rates of decline in eGFR † | 0.52 ± 0.04* | 0.74 ± 0.04 | 0.61 ± 0.03* | 0.71 ± 0.03 | 1.03 ± 0.08 | 0.97 ± 0.10 |
Covariate-adjusted rates of decline in eGFR † (referenced to healthy group) | - | - | 0.10 ± 0.04& | -0.03 ± 0.04 | 0.51 ± 0.08& | 0.20 ± 0.07& |
Gender difference of covariate adjusted rates of decline in eGFR † (referenced to healthy group) | - | 0.09 ± 0.06 | 0.31 ± 0.10# | |||